Evidence map›Paper›PMID 40592956›Full record

ArticleScientific reports2025

Heat capacity and thermodynamic functions of crystalline and amorphous forms of Lovastatin.

Maria Brycka, Agata Olszewska, Natalie Parkinson, Christopher Hoban, Anna Czerniecka-Kubicka, Marek Pyda, Brian F Woodfield, Marcin Skotnicki

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maria BryckaIndustrial Pharmacy Division, Chair and Department of Pharmaceutical Technology, Poznan, University of Medical Sciences, ul. Rokietnicka 3, Poznan, 60-806, Poland.
Agata OlszewskaIndustrial Pharmacy Division, Chair and Department of Pharmaceutical Technology, Poznan, University of Medical Sciences, ul. Rokietnicka 3, Poznan, 60-806, Poland.
Natalie ParkinsonDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT, 84604, USA.
Christopher HobanDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT, 84604, USA.
Anna Czerniecka-KubickaDivision of Pharmaceutical Technology and Medical Physics, Medical College of Rzeszow University, The University of Rzeszow, al. Tadeusza Rejtana 16C, Rzeszow, 35-310, Poland.
Marek PydaDepartment of Chemistry, University of Tennessee, Knoxville, TN, 37996-1600, USA.
Brian F WoodfieldDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT, 84604, USA.
Marcin SkotnickiIndustrial Pharmacy Division, Chair and Department of Pharmaceutical Technology, Poznan, University of Medical Sciences, ul. Rokietnicka 3, Poznan, 60-806, Poland. marcskot@ump.edu.pl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The thermal behavior of crystalline and amorphous lovastatin was studied using advanced thermal analysis, including the Quantum Design Physical Property Measurement System and Differential Scanning Calorimetry. Equilibrium lines for liquid and solid states were determined from experimental heat capacity values, allowing for the calculation of state functions. The Kauzmann temperature (T

Indexed as

LovastatinCalorimetry, Differential ScanningCrystallizationHot TemperatureTemperatureThermodynamicsLovastatinAmorphous phaseDifferential scanning calorimetryHeat capacityLovastatinPhysical ageing

Identifiers

PMID40592956
PMCPMC12217180

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.